GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » E10

Biotage AB (Biotage AB) E10 : $0.27 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biotage AB's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.27 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Biotage AB's average E10 Growth Rate was 11.50% per year. During the past 3 years, the average E10 Growth Rate was 21.80% per year. During the past 5 years, the average E10 Growth Rate was 42.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biotage AB was 56.10% per year. The lowest was 21.80% per year. And the median was 47.40% per year.

As of today (2024-04-30), Biotage AB's current stock price is $14.63. Biotage AB's E10 for the quarter that ended in Mar. 2024 was $0.27. Biotage AB's Shiller PE Ratio of today is 54.19.

During the past 13 years, the highest Shiller PE Ratio of Biotage AB was 267.45. The lowest was 31.87. And the median was 125.48.


Biotage AB E10 Historical Data

The historical data trend for Biotage AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB E10 Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.18 0.22 0.23 0.26

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.24 0.25 0.26 0.27

Competitive Comparison of Biotage AB's E10

For the Medical Instruments & Supplies subindustry, Biotage AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's Shiller PE Ratio falls into.



Biotage AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotage AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.04/130.9575*130.9575
=0.040

Current CPI (Mar. 2024) = 130.9575.

Biotage AB Quarterly Data

per share eps CPI Adj_EPS
201406 0.036 100.432 0.047
201409 0.024 100.161 0.031
201412 0.062 100.225 0.081
201503 0.034 99.950 0.045
201506 0.029 99.995 0.038
201509 0.033 100.228 0.043
201512 0.038 100.276 0.050
201603 0.042 100.751 0.055
201606 0.046 101.019 0.060
201609 0.050 101.138 0.065
201612 0.029 102.022 0.037
201703 0.062 102.022 0.080
201706 0.067 102.752 0.085
201709 0.060 103.279 0.076
201712 0.063 103.793 0.079
201803 0.084 103.962 0.106
201806 0.090 104.875 0.112
201809 0.076 105.679 0.094
201812 0.047 105.912 0.058
201903 0.079 105.886 0.098
201906 0.088 106.742 0.108
201909 0.105 107.214 0.128
201912 0.031 107.766 0.038
202003 0.095 106.563 0.117
202006 0.053 107.498 0.065
202009 0.064 107.635 0.078
202012 0.081 108.296 0.098
202103 0.108 108.360 0.131
202106 0.083 108.928 0.100
202109 0.094 110.338 0.112
202112 0.076 112.486 0.088
202203 0.113 114.825 0.129
202206 0.087 118.384 0.096
202209 0.090 122.296 0.096
202212 0.107 126.365 0.111
202303 0.062 127.042 0.064
202306 0.046 129.407 0.047
202309 0.043 130.224 0.043
202312 0.169 130.958 0.169
202403 0.040 130.958 0.040

Add all the adjusted EPS together and divide 10 will get our e10.


Biotage AB  (OTCPK:BITGF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biotage AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=14.63/0.27
=54.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Biotage AB was 267.45. The lowest was 31.87. And the median was 125.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biotage AB E10 Related Terms

Thank you for viewing the detailed overview of Biotage AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 08-18-2020

Biotage AB (publ) Interim report January-September 2020

By PRNewswire PRNewswire 11-05-2020

Biotage - Change in number of shares and votes

By PRNewswire PRNewswire 10-29-2021

Biotage AB (publ) Interim report January - June 2021

By PRNewswire PRNewswire 07-16-2021

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

New capacity helps eliminate bottleneck for COVID-19 vaccines

By PRNewswire PRNewswire 08-16-2021

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021

Biotage Awarded Gold Sustainability Medal by EcoVadis

By PRNewswire PRNewswire 02-24-2022